Gelteq Limited
GELSPre-clinicalGelteq Limited is a development-stage biotech company leveraging its proprietary gel technology platform to address significant unmet medical needs in drug delivery. The company is advancing a pipeline of reformulated and novel therapeutics, with a strategic focus on improving patient outcomes through enhanced bioavailability and controlled release. As a publicly listed entity on the Australian Securities Exchange, Gelteq is positioned to capitalize on partnerships and further development of its platform. Its core mission is to transform treatment paradigms in challenging therapeutic areas.
GELS · Stock Price
Historical price data
AI Company Overview
Gelteq Limited is a development-stage biotech company leveraging its proprietary gel technology platform to address significant unmet medical needs in drug delivery. The company is advancing a pipeline of reformulated and novel therapeutics, with a strategic focus on improving patient outcomes through enhanced bioavailability and controlled release. As a publicly listed entity on the Australian Securities Exchange, Gelteq is positioned to capitalize on partnerships and further development of its platform. Its core mission is to transform treatment paradigms in challenging therapeutic areas.
Technology Platform
Proprietary gel-based drug delivery platform designed to enhance solubility, stability, bioavailability, and controlled release of pharmaceutical compounds.
Funding History
3Total raised: $27.5M
Opportunities
Risk Factors
Competitive Landscape
Competes with numerous established drug delivery firms and small biotech innovators. Differentiation hinges on proving superior performance of its gel technology in enhancing drug profiles and creating strong, defensible intellectual property.
Company Info
Trading
Contact
Therapeutic Areas
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile